Numerical aberrations of chromosome 17 in interphase cell nuclei of breast carcinoma cells: Lack of correlation with abnormal expression of p53, neu and nm23 protein

APMIS

Volumn 106, Issue 10, 1998, Pages 921-927

  Sauer, Torill ^a   Beraki, Kahsai ^a   Jebsen, Peter W ^a   Ormerod, Eli ^a   Næss, Oddvar ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Breast carcinoma; In situ hybridization; Neu; nm23; Numerical chromosomal aberrations; p53

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CHROMOSOME 17; CHROMOSOME ABERRATION; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; INTERPHASE; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031759718     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00240.x     Document Type: Article

References (32)

1. Andersen, T. I., Gaustad, A., Ottestad, L., Farrants, G. W., Nesland, J. M., Tveit, K. M. et al.: Genetic alterations of the tumor suppressor gene regions 3p, 11p, 13q, 17q and 17p in human breast carcinomas. Genes Chromosomes Cancer 4: 113-121, 1992.
2. Backer, J. M., Mendola, C. E., Kovesdi, I., O'Hara, B., Eddy, R. L. Jr. et al.: Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes nm23-1 and nm23-2. Oncogene 8: 497-502, 1993.
3. Bacus, S. S., Bacus, J. W., Slamon, D. J. & Press, M. F.: HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer. Arch. Pathol. Lab. Med. 114: 164-169, 1990.
4. Bevilaqua, G., Sobel, M. E., Liotta, L. A. & Steeg, P. S.: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 49: 5185-5190, 1989.
5. Caligo, M. A., Ghimenti, C. & Bevilaqua, G.: Nm23-H1 loss of heterozygosity in human mammary carcinomas. Definition of a deletion map on chromosome 17q. Ann. N Y Acad. Sci. 698: 136-142, 1993.
6. Chen, H.-C., Wang, L. & Banerjee, S.: Isolation and characterization of the promotor region nm23-H1, a metastasis suppressor gene. Oncogene 9: 2905-2912, 1994.
7. Chen, L., Kurisu, W., Ljung, B. M., Goldman, E. S., Moore, D. II. & Smith, H. S.: Heterogeneity for allelic loss in human breast cancer, JNCI 84: 506-510, 1992.
8. Courjal, F., Cuny, M., Simony-Lafontaine, J., Louason, G. et al.: Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res. 57: 4360-4367, 1997.
9. Courjal, F. & Theillet, C.: Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res. 57: 4368-4377, 1997.
10. Dawkins, H. J. S., Robbins, P. D., Smith, K. L., Sarna, M., Harvey, J. M., Sterrett, G. F. & Papadimitrou, J. M.: What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease. Path. Res. Pract. 189: 1233-1252, 1993.
11. De Potter, C. R. & Shelfout, A.-M.: The neu-protein and breast cancer. Virchows Archiv. 426: 107-115, 1995.
12. Devilee, P., Tierry, R. F., Kievits, T., Kolluri, R., Hopman, A. H. N., Willard, H. F., Pearson, P. L. & Cornelisse, C. J.: Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res. 48: 5825-5830, 1988.
13. Devilee, P., van Vliet, M., van Sloun, P. et al.: Allelotype of human breast carcinoma: a second major site for loss of heterozygocity is on chromosome 6q. Oncogene 6: 1705-1711, 1991.
14. Herrington, C. S., Leek, R. D., McGee, J. O'D.: Correlation of numerical chromosome 11 and 17 imbalances with metastasis of primary breast cancer to lymph nodes. J. Pathol. 176: 353-359, 1995.
15. Ichikawa, D., Hashimoto, N., Hoshima, M., Yamaguchi, T., Sawai, K., Nakamura, Y., Takahashi, T., Abe, T. & Inazawa, J.: Analysis of numerical aberrations in specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer. Cancer 77: 2064-2069, 1996.
16. Kuukaservi, T., Tanner, M., Pennanen, S., Karhu, R., Kallionemi, O.-P. & Isola, J.: Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am. J. Pathol. 150: 1465-1471, 1997.
17. Kuukaservi, T., Karhu, R., Tanner, M., Kahkoenen, M., Schaffer, A., Nupponen, N., Pennanen, S., Kallionemi, A., Kallionemi, O.-P. & Isola, J.: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57: 1597-1604, 1997.
18. Lee, A. K., Wiley, B., Loda, M. et al.: DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinomas. Mod. Pathol. 5: 61-67, 1992.
19. Leone, A., McBride, O. W., Weston, A., Wang, M. G., Anglard, P., Cropp, C. S. et al.: Somatic allelic deletion of nm23 in human cancer. Cancer Res. 51: 2490-2493, 1991.
20. Leong, A. S.-Y. & Lee, A. K. C.: Biological indices in the assessment of breast cancer. J. Clin., Pathol. Mol. Pathol. 48: M221-238, 1995.
21. Pandis, N., Heim, S., Bardi, G., Idvall, I., Mandahl, N. & Mitelman, F.: Whole-arm t(1,16) and i(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer 5: 235-238, 1992.
22. Pandis, N., Jin, Y., Gorunova, L., Petersson, C., Bardi, G., Idvall, I., Johanson, B., Ingvar, C., Mandahl, N., Mitelman, F. & Heim, S.: Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12: 173-185, 1995.
23. Royds, J. A., Stephenson, T. J., Rees, R. C., Shorthouse, A. J. & Silcocks, P. B.: Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J. Natl. Cancer Inst. 85: 727-731, 1993.
24. Russell, R. L., Geisinger, K. R., Metha, R. R., White, W. L., Shelton, B. & Kute, T. E.: nm23 relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients. Cancer 79: 1158-1165, 1997.
25. Sauer, T., Beraki, K., Jebsen, P. W., Ormerod, E. & Næss, O.: In situ hybridization of chromosome 6 on fine-needle aspirates from breast carcinomas: comparison of numerical abnormalities and ER/PgR status and staining pattern. Diagn. Cytopathol. 16: 420-424, 1997.
26. Sauer, T., Beraki, K., Jebsen, P. W., Ormerod, E. & Næss, O.: Ploidy analysis by in situ hybridization of interphase cell nuclei in fine-needle aspirates from breast carcinomas: correlation with cytologic grading. Diagn. Cytopathol. 17: 267-271, 1997.
27. Sauer, T., Furu, I., Beraki, K., Jebsen, P. W., Ormerod, E. & Næss, O.: Nm23 protein expression in fine needle aspirates from breast carcinomas: Inverse correlation with cytologic grading, lymph node status and ploidy. Cancer Cytopathol. (in press).
28. Steeg, P. S., De La Rosa, A., Flatow, U., MacDonald, N. J., Benedict, M. & Leone, A.: Nm23 and breast cancer metastasis. Breast Cancer Res. Treat. 25: 174-187, 1993.
29. Tokunaga, Y., Urano, T., Furukawa, K., Kondo, H., Kanematsu, T. & Shiku, H.: Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer 55: 66-71, 1993.
30. Troncone, G., Zeppa, P., Fulcinti, F. et al.: C-erbB-2 expression and DNA ploidy status in breast cancer cells obtained by fine needle aspiration (FNA). Cytopathology 4: 195-205, 1993.
31. Visscher, D. W., Sarkar, F. H. & Crissmann, J. D.: Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors. Anal. Quant. Cytol. Histol. 13: 418-424, 1991.
32. Yamashita, H., Kobayashi, S., Iwase, H., Itoh, Y., Kuzushima, T., Iwata, H. et al.: Analysis of oncogenes and tumor suppressor genes in human breast cancer. Jpn. J. Cancer Res. 84: 871-878, 1993.